HomeSPH • WSE
add
Sopharma AD
Previous close
zł 15.00
Day range
zł 15.00 - zł 15.00
Year range
zł 11.40 - zł 15.60
Avg Volume
489.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (BGN) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 644.06M | 25.43% |
Operating expense | 110.48M | 28.78% |
Net income | 40.33M | 35.74% |
Net profit margin | 6.26 | 8.12% |
Earnings per share | — | — |
EBITDA | 56.30M | 23.22% |
Effective tax rate | 11.02% | — |
Balance Sheet
Total assets
Total liabilities
| (BGN) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 52.11M | 87.37% |
Total assets | 1.94B | 19.78% |
Total liabilities | 1.06B | 30.36% |
Total equity | 887.50M | — |
Shares outstanding | 166.36M | — |
Price to book | 2.91 | — |
Return on assets | 5.51% | — |
Return on capital | 7.45% | — |
Cash Flow
Net change in cash
| (BGN) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | 40.33M | 35.74% |
Cash from operations | -30.11M | 80.79% |
Cash from investing | -7.19M | -294.19% |
Cash from financing | 53.77M | -0.34% |
Net change in cash | 16.48M | 115.76% |
Free cash flow | -50.81M | 70.25% |
About
Founded
1933
Website
Employees
6,099
